PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
229.02 - 234.51
169.21 - 260.10
55.82M / 54.92M (Avg.)
32.24 | 7.26
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-31.29%
Negative net income growth while VUZI stands at 11.25%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
8.62%
Less D&A growth vs. VUZI's 22.92%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
-36.08%
Negative yoy deferred tax while VUZI stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
No Data
No Data available this quarter, please select a different quarter.
-152.63%
Both reduce yoy usage, with VUZI at -19.64%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
100.00%
AR growth while VUZI is negative at -73.35%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
-1596.44%
Negative yoy inventory while VUZI is 80.56%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-100.00%
Both negative yoy AP, with VUZI at -192.98%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-100.00%
Negative yoy usage while VUZI is 352.14%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
202.57%
Well above VUZI's 100.00%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-167.01%
Both yoy CFO lines are negative, with VUZI at -38.64%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-9.48%
Both yoy lines negative, with VUZI at -18.60%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
67.89%
Purchases growth of 67.89% while VUZI is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-26.83%
We reduce yoy sales while VUZI is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-177.88%
We reduce yoy other investing while VUZI is 6.90%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
314.45%
We have mild expansions while VUZI is negative at -13.57%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
No Data
No Data available this quarter, please select a different quarter.
139.02%
Stock issuance far above VUZI's 124.06%. Michael Burry flags a significant dilution risk vs. competitor’s approach unless ROI is very high.
-103.46%
We cut yoy buybacks while VUZI is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.